WFDC2 and renal fibrosis: HE4 is elevated in the serum of CKD patients and is correlated with decreased kidney function and an advanced stage of renal fibrosis, suggesting that HE4 might be a valuable clinical biomarker of renal fibrosis in CKD [9, 10].